Cyclooxygenase (COX) and lipoxygenase (LOX) can catalyze the oxidation of C20 fatty acids to produce certain eicosanoids, which play roles in mediating immune responses in insects. Despite their critical role in insect immunity, there have been few studies of the unique effects of different eicosanoids on immune responses. This study analyzed cellular and humoral immune responses of the beet armyworm, Spodoptera exigua, using seven eicosanoids selected from two major eicosanoid subgroups: prostaglandin (PG) and leukotriene (LT), derived from catalytic activities of COX and LOX respectively. Upon bacterial challenge, all seven eicosanoids (PGA 1 , PGB 2 , PGD 2 , PGE 1 , PGE 2 , PGF 1 , and LTB 4 ) significantly induced hemocyte nodulation and phagocytosis in the presence of dexamethasone, an eicosanoid biosynthesis inhibitor. However, only PGs induced cell lysis of oenocytoids to release prophenoloxidase, which resulted in an increase in phenoloxidase activity. These seven eicosanoids also induced expression of humoral immune-associated genes, including prophenoloxidase, serpin, dopa decarboxylase, cecropin, and lysozyme, in which PGB 2 and PGE 1 did not induce gene expression of prophenoloxidase. To understand the interactions between different eicosanoids, mixture effects of these eicosanoids were compared with their individual eicosanoid effects on mediating nodule formation in response to bacterial challenge. All six single PGs showed increases in nodule formation in a dosedependent manner without significant difference among the different types. LTB 4 was more potent than the tested PGs in mediating the cellular immune response. At low doses, all combinations of two eicosanoids showed significant additive effects on nodule formation. These results indicate that immune target cells, such as hemocyte and fat body, of S. exigua can respond to different COX and LOX products to express cellular and humoral immune responses, and their overlapping, additive effects on nodulation suggest that in target cells, these eicosanoids share a hypothetical common eicosanoid signal pathway.
undergoes three different oxidation processes via cyclooxygenase (COX), lipoxygenase (LOX), and epoxygenase respectively. 1) These eicosanoid biosynthesis pathways are commonly initiated by phospholipase A 2 (PLA 2 ), which cleaves phospholipid at sn-2.
2) Eicosanoids mediate various physiological processes of various biological systems, including reproduction, excretion, ion transport, and immune defense. 3) Insect immune responses are innate and are classified into cellular and humoral types. 4) After non-self recognition by pattern-recognition receptors, the immune signal can be relayed by mediators, such as cytokines, monoamines, and eicosanoids. 5) In cellular immune responses, circulating hemocytes participate to defend against the invading pathogen and perform phagocytosis, nodulation, and encapsulation. 6) Humoral immune responses are characterized by synthesis and the release of various antimicrobial peptides. 7) Numerous assays using eicosanoid biosynthesis inhibitors indicate that eicosanoids mediate cellular, humoral, or both defense responses in response to bacterial infection in different insect orders. 8) It also mediates immune responses against fungal and viral infections. [9] [10] [11] Indeed, eicosanoids are biosynthesized in insect immune tissues, in which several prostaglandins (PGA 2 , PGE 2 , PGD 2 , and PGF 2 ) and 15-hydroxyeicosatetraenoic acid have been identified in the fat body and hemocytes of Manduca sexta, 12, 13) but, little is known about the effects of each type of endogenous eicosanoids on specific cellular and humoral immune responses, though some recent studies have indicated the effects of specific PGs on the mediation of gene expression. 14, 15) Different eicosanoids may mediate specific immune responses in insects. For example, microaggregation of hemocytes in response to bacterial challenge is required to form nodules, which are mediated by COX products not by LOX products in M. sexta. 16) Phenoloxidase activity is required to form melanin during either nodule formation or encapsulation response by hemocytes. 17) Its inactive form is stored in a specific hemocyte, oenocytoid, and is released by cell lysis through the mediation of COX products, not by LOX products, in Spodoptera exigua. 18) In addition, when cultured cells are exposed to PGA 2 or PGE 2 , these PGs induce differential gene expression. 15) y To whom correspondence should be addressed. Fax: +82-54-820-5638; E-mail: hosanna@andong.ac.kr Abbreviations: COX, cyclooxygenase; LOX, lipoxygease; AA, arachidonic acid; DEX, dexamethasone; PG, prostaglandin; LT, leukotriene; RT-PCR, reverse transcriptase-polymerase chain reaction
To investigate the specific roles of various eicosanoids, we analyzed their effects on cellular and humoral immune responses of S. exigua using six COX products (both conventional and cyclopentenone subtypes) and a LOX product. To test the effect of each eicosanoid type, endogenous eicosanoid biosynthesis was inhibited by dexamethasone, a specific inhibitor of PLA 2 , and then each eicosanoid was added exogenously to test for significant recovery of a specific immune response. This study revealed specific effects of each eicosanoid type on different cellular and humoral immune responses, and also showed their additive effects in S. exigua. Finally, it suggested a common intracellular signal pathway of these eicosanoids in target cells by demonstrating significant additive effects of COX and LOX products.
Materials and Methods
Insect and bacterial cultures. Larvae of S. exigua were fed an artificial diet 19) at 25 AE 1 C. Two days-old fifth instar larvae were used. Escherichia coli Top10 was cultured in Lauria Bertani broth (Difco, Detroit, MI) overnight at 37 C with 200 rpm shaking.
Chemicals. Dexamethasone (DEX) [(11,16 and 138 mM NaCl, and adjusted to pH 7.4. Tris-buffered saline (TBS) was prepared with 50 mM Tris-HCl, 100 mM dextrose, 5 mM KCl, 2.5 mM MgCl 2 , and 50 mM NaCl at pH 7.5. For preparation of anticoagulant buffer (ACB), 4 mg of L-cysteine . HCl (Sigma-Aldrich Korea) dissolved in 5 ml of TBS was used, and the pH was adjusted to 7.5 using 0.1 N NaOH.
Nodulation assay. Each test larva was injected with 4 ml of bacteria (3:2 Â 10 4 cells) and test solution through its abdominal proleg using a Hamilton syringe (Hamilton, Reno, NV). Before injection, larvae were pre-chilled on ice and wiped with 70% ethanol for surface sterilization. After 4 h of incubation at 25 C, the treated larvae were dissected on the dorsal side, and the melanized nodules on the gut and fat body were initially counted under a stereoscopic microscope (SZX9, Olympus, Tokyo) at 50Â magnification. After the alimentary canal was excised, nodules in the previously unexposed areas and remaining internal tissues were counted and added to the initial count.
Phagocytosis assay. Hemolymph (about 50 ml) of a fifth instar S. exigua larva was collected in 950 ml of ACB by cutting the abdominal proleg. The hemolymph was centrifuged at 5,000 rpm for 5 min. After the supernatant was removed, the hemocytes were resuspended in PBS. The hemocyte suspension (100 ml) was then used to form a monolayer on sterilized glass slides at 25 C in a moist chamber. After 20 min, the hemocyte monolayer was overlaid with fluorescein isothiocyanate (FITC)-labeled E. coli bacteria (hemocyte:bacteria ¼ 1:10) prepared by the method of Shrestha and Kim, 20) and incubated under darkness. After 1 h, the monolayer was washed carefully 3 times with PBS and supplemented with one drop of 1% glutaraldehyde for cell fixation. After 10 min of incubation, the monolayer was covered with a sterilized cover slip and observed under a confocal microscope (IX70, Olympus) in FITC or DIC (differential interference contrast) mode after quenching with 0.05% trypan blue.
Oenocytoid lysis assay. A hemocyte suspension was prepared as described above. For the reaction, 94 ml of hemocyte suspension was incubated with 2 ml of DEX (50 mg/ml) on a sterilized slide glass in a moist chamber for 5 min at 25 C. Then 2 ml of E. coli (5:8 Â 10 4 cells) and 2 ml of test eicosanoid were added. After 20 min of incubation, the oenocytoids were counted among 100 hemocytes randomly chosen under a phase contrast microscope (BX41, Olympus). The oenocytoids were identified by morphological characteristics, 21) such as large cell size (>15 mm diameter) and lack of cytoplasmic inclusions.
Phenoloxidase (PO) activity. Hemolymph PO activity was quantitatively determined with L-3,4-dihydroxyphenylalanine (DOPA), as described by Shrestha and Kim. 22) Ninety-four ml of hemolymph was incubated with 2 ml of DEX (50 mg/ml) for 10 min at 25 C. Then 2 ml of E. coli (5:8 Â 10 4 cells) and 2 ml of test eicosanoid were added to the hemolymph sample and this was further incubated for 5 min. After 900 ml of PO substrate solution containing 1 mg of DOPA in PBS was added, initial absorbance change was monitored at 495 nm.
Reverse transcriptase-polymerase chain reaction (RT-PCR). The whole body of a fifth instar S. exigua larva after 4 h of injection with the test chemical was used to extract total RNA using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. First-strand cDNA was prepared by reverse transcription using RT-premix (Intron Biotechnology, Seoul) containing oligo dT primer (5 0 -CCAGTGAGCAGAGTGCGAGGACTCGAGCTCAAGCTTTTT-TTTTTTTTTTTT-3 0 ). Ten-times diluted cDNA was used as the template for RT-PCR with gene specific forward and reverse primers (Table 1) . PCR was performed at 35 cycles under conditions of denaturation at 95 C for 1 min, extension at 72 C for 1 min, and at a specific annealing temperature for each gene for 1 min.
Statistical analysis. All studies were performed in three independent replicates and were plotted by mean AE standard deviation using a sigma plot. Means were compared by a least squared differences (LSD) test of ANOVA using PROC GLM of the SAS program, 23) and were discriminated at type I error ¼ 0.05.
Results
Effects of COX and LOX products on different cellular immune responses in S. exigua
As expected from a previous study, 24) 100 mg of dexamethasone was enough to inhibit nodule formation of a fifth instar larva of S. exigua in response to bacterial challenge ( Fig. 1 ). Under this inhibitory condition, each addition of a COX or LOX product significantly 39) and PPO (prophenoloxidase, EF684939).
recovered the cellular immune response. None of the seven eicosanoids showed a significant difference (F ¼ 231:62; df ¼ 6, 12; p ¼ 0:5721) in their mediation of nodule formation. All eicosanoids were used at 500 ng injection dose, except for LTB 4 , which was used at 200 pg due to its high activity (see below), but a LTB 4 was highly cytotoxic to hemocytes at high nanogram doses. Subsequent experiments used 200 pg or smaller doses of LTB 4 .
Two phagocytotic hemocyte types (granular cells and plasmatocytes) of S. exigua 20) were tested to analyze the effects at eicosanoids in mediating phagocytosis (Fig. 2) . Again, 100 mg of dexamethasone was effective at inhibiting phagocytosis in both hemocyte types. Under this inhibitory condition, each addition of a COX or LOX product significantly recovered the cellular immune response in granular cells ( Fig. 2A) . However, the rescue effects were different among different eicosanoids (F ¼ 0:23; df ¼ 6, 12; p ¼ 0:0130), of which the effect of PGF 1 was the smallest. Similarly, all these eicosanoids except for PGF1 significantly rescued the phagocytotic activity in the plasmatocytes (Fig. 2B ). Compared to granular cells, the differential effects of the eicosanoids were more significant in plasmatocytes (F ¼ 0:52; df ¼ 6, 12; p ¼ 0:0107).
Prophenoloxidase is stored in the oenocytoids of S. exigua and is released by cell lysis in response to bacterial challenge, which is mediated by COX products. 18) Injection of dexamethasone (100 mg) was effective at inhibiting oenocytoid cell lysis in response to bacterial challenge (Fig. 3) . However, the addition of six different PGs significantly induced cell lysis, though a LOX product (LTB 4 ) did not have any inducing effect (Fig. 3A) . The effects in inducing cell lysis were not significantly different among the six PGs at the same dose (F ¼ 1:77; df ¼ 5, 10; p ¼ 0:2064), but the effect of PGA 1 appeared to be the strongest. 200Â magnification) . Arrows indicate FITC-labeled bacteria. B, Hemocyte suspension (94 ml) was treated with 2 ml of dexamethasone (DEX) plus 2 ml of a prostaglandin (PG, 500 ng) or a leukotriene (LT, 200 pg) and 2 ml of FITC-bacteria. Control represents hemocyte and bacterial suspension with ethanol (4 ml) in places of DEX and eicosanoid. One hundred hemocytes were randomly chosen in the DIC mode, in which phagocytotic cells were counted in the FITC mode. Each treatment was replicated 3 times. Different letters above standard deviation bars indicate significant differences among their means at type I error ¼ 0.05 (LSD test).
In view of the causative role of oenocytoid lysis in the activation of prophenoloxidase, 18) phenoloxidase activity in the plasma was measured after bacterial challenge (Fig. 3B) . Bacterial challenge significantly increased phenoloxidase activity, which was completely inhibited by the addition of dexamethasone (100 mg). Except for LTB 4 , all the PGs significantly rescued the activity of phenoloxidase, but the rescue effects were different among eicosanoids at the same dose (F ¼ 3:71; df ¼ 5, 10; p ¼ 0:0368). Oenocytoid lysis and phenoloxidase activity appeared to be negatively correlated (r ¼ À0:3142; df ¼ 24; P ¼ 0:1349) among the seven eicosanoid treatments.
Effects of COX and LOX products on the expression of immune-associated genes in S. exigua Individual eicosanoid was analyzed for its effect on the expression of immune-associated genes (Fig. 4) . Before these assays, we tested the overall eicosanoid effect on gene expression using dexamethasone, which inhibits synthesis of endogenous types of eicosanoids (Fig. 4A) . Five different immune-associated genes (cecropin, serpin-2, lysozyme, prophenoloxidase, and dopa decarboxylase) of S. exigua showed inducible expression in response to bacterial challenge. Expression of these genes was inhibited by the addition of 100 mg of dexamethasone, but the inhibitory effects of dexamethasone varied at doses less than 100 mg depending on the corresponding gene types. Under a complete inhibitory condition, each addition of a COX or LOX product rescued this gene expression, but expression of prophenoloxidase was not induced in the presence of PGB 2 or PGE 1 .
Additive effects of COX and LOX products on nodule formation
The above eicosanoid assays indicated that individual COX and LOX products can mediate several immune A, Oenocytoid lysis. A hemocyte suspension (94 ml) was treated with 2 ml of dexamethasone (DEX) plus 2 ml of a prostaglandin (PG, 500 ng) or a leukotriene (LT, 200 pg) and 2 ml of Escherichia coli (5:8 Â 10 4 cells). Control represents hemocyte and bacterial suspension with ethanol (4 ml) in places of DEX and eicosanoid. DEX was treated along with a PG (500 ng) or LT (200 pg) into the hemocoel of each fifth instar S. exigua larva. After 20 min incubation on a slide glass in a moist environment, oenocytoids were counted among 100 randomly chosen hemocytes under a phase contrast microscope (BX41, Olympus). B, PO activity. A hemolymph (94 ml) was treated with 2 ml of DEX plus 2 ml of a PG (500 ng) or a LT (200 pg) and 2 ml of Escherichia coli (5:8 Â 10 4 cells). Control represents hemolymph and bacterial suspension treated with ethanol (4 ml) used for solvent of DEX and eicosanoid. After the addition of 900 ml of substrate solution containing DOPA (1 mg), the initial absorbance change at 495 nm was recorded as enzyme activity. Each treatment was replicated 3 times. Different letters above standard deviation bars indicate significant differences among their means at type I error ¼ 0.05 (LSD test). Cec-A, Lyz, PPO, Spn-2, and DDC represent cecropin A, lysozyme, prophenoloxidase, serpin 2, and dopa decarboxylase respectively. See Table 1 for the sources of the genes and their primer sequences for RT-PCR analyses. A, Inhibitory effect of dexamethasone (DEX) on gene expression. Doses of DEX were injected along with Escherichia coli (3:8 Â 10 4 cells) into fifth instar S. exigua larvae. B, DEX was injected along with a prostaglandin (PG, 500 ng) or leukotriene (LT, 200 pg) and bacteria into the hemocoel of each fifth instar S. exigua larva. After 4 h of injection, total RNA was extracted using Trizol reagent, and then cDNA was constructed with 1 mg of RNA for RT-PCR. Ten-times diluted cDNA was used to check gene expression patterns.
responses, including cellular and humoral responses, when they are added in excess quantity (500 ng for PGs and 200 pg for LTB 4 ). Hence we analyzed individual COX and LOX products quantitatively by determining their dose-responses (Fig. 5) . Except for LTB 4 , all the PGs were prepared at the same doses in the presence of dexamethasone (100 mg). The tested eicosanoids induced significant increases in nodule formation in S. exigua with increasing doses (F ¼ 52:52; df ¼ 3, 56; p < 0:0001). None of the tested eicosanoids showed significant differences in these dose-response patterns (F ¼ 1:07; df ¼ 18, 56; p ¼ 0:4019). In the LTB 4 treatment, doses over 200 pg did not show any increase in nodulation, but were cytotoxic to hemocytes (data not shown).
We tested the additive effects of eicosanoids by preparing combinatorial mixtures of two different COX and LOX products at a low dose (5 ng). Twenty-one combinations of COX and LOX products were analyzed as to their effects in mediating nodule formation, and we compared the values obtained with the expected values by adding effects of two single eicosanoid treatments ( Table 2 ). All the combinatorial eicosanoid treatments were well suited to this additive model.
Discussion
Each of the COX and LOX products analyzed in this study had significant effects on the cellular or humoral immune responses of S. exigua. The effects of these eicosanoids on cellular immune responses in this species support previous studies of eicosanoid biosynthesis inhibitors, 20, 24, 25) but eicosanoids in this study showed differential effects in inducing immune reactions in response to bacterial challenge, though they were not much different in mediating hemocyte nodule formation. Hemocytic nodulation is known to be mediated by various eicosanoids in more than 20 different insect species. 26, 27) Moreover, nodule formation mediated by eicosanoids is not confined to bacterial infection, but is also found due to fungal, protozoan, or virus infection. 9, 11, 28) A previous study found that hemocytic nodulation of S. exigua is dependent on various eicosanoid because all three eicosanoid biosynthesis inhibitors (dexamethasone, inhibiting PLA 2 ; naproxen, inhibiting COX; and esculetin, inhibiting LOX) significantly inhibited the cellular immune response. 24) Indeed, hemocytes of M. sexta can produce both prostaglandins and leukotrienes. 12) Except for PGF 1 , all the tested eicosanoids significantly induced phagocytosis of two hemocytes, granular cells and plasmatocytes, which are the main phagocytotic cells in S. exigua. 20) In M. sexta, several eicosanoids (PGA 2 , PGD 2 , PGE 2 , PGF 2 , and 15-hydroxyeicosatetraenoic acid) have been identified in microsomalenriched preparations of hemocyte and fat body. 12, 13) PGF 2 was also detected in the plasma of bacteriachallenged Pseudaletia unipuncta.
29) The presence of PGF 2 in hemocyte and plasma, though its physiological function is not known in M. sexta and P. unipunta, suggests its importance in immune mediation. The relatively poor mediation effect of PGF 1 in S. exigua might probably explained by rare production in insects, because it is derived from a different biosynthetic precursor, dihomolinolenic acid (20:3 !-6), as compared to PGF 2 from arachidonic acid. 30 ) LTB 4 significantly modulated the hemocyte activity of S. exigua. No invertebrate has been found to synthesize this eicosanoid, due to lack of appropriate synthesizing enzymes, such as LTA 4 hydrolase and 5-lipoxygenase.
As expected from a study of Shrestha and Kim, 18) a LOX product, LTB 4 , was poor in mediating cell lysis of oenocytoids, though all tested PGs showed significant induction. This is also well supported by induction of phenoloxidase activity in the plasma of S. exigua after eicosanoid treatment, because there is a positive correlation between prophenoloxidase activation and eicosanoids in this species. 25, 31) Prophenoloxidase is expressed only in a specific hemocyte type, oenocytoids, in S. exigua.
18) Activation of prophenoloxidase occurs in the plasma by serine proteinase cascade in S. exigua, because serine protease inhibitors inhibited the activation. 22) Indeed, in M. sexta, an array of activated reactions of serine proteinases finally induces activation of a final proteolytic enzyme (prophenoloxidase-activating proteinase, PAP) that specifically cleaves prophenoloxidase. 32) PAP has been identified in several insects, including M. sexta, [32] [33] [34] B. mori, 35) and Holotrichia diomphalia, 36) and a crustacean, Pacifastacus leniusculus. 37) In the absence of signal peptide, the movement of prophenoloxidase in the oenocytoids into the plasma of S. exigua is accomplished by cell lysis, which is mediated by eicosanoids, especially PGs, not LOX products. 18) Similarly, in Drosophila melanogaster, comprising four major hemocyte subtypes, crystal cells are specialized in synthesizing and storing prophenoloxidase, which is released by cell rupture after injury or infection via a specific signal pathway, including Jun N-terminal kinase, small Rho GTPases, and Eiger. 38) Thus current studies using S. exigua suggest that the release of C, the larvae were dissected to count round black nodules on the gut and fat body under a stereoscopic microscope (SZX9, Olympus) at 50Â magnification. Each treatment included at least 10 larvae. prophenoloxidase from its source hemocytes is induced by PGs, which interact on PG receptors to turn on the signal pathway, resulting in cell lysis. Some differential effects among PGs tested inducing cell lysis of oenocytoids are explained by reference to their different relationship with their cognate receptors.
This study indicates the effects of COX and LOX products on induction of immune-associated genes in S. exigua. All four genes were inducible on bacterial infection, which was inhibited by dexamethasone. The inhibitory activity of dexamethasone on gene expression was dose-dependent. For example, expression of cecropin was not inhibited at 10 mg of dexamethasone in S. exigua, but was significantly inhibited by an entomopathogenic bacterium, Xenorhabdus nematophila, which is known to inhibit PLA 2 .
39) The addition of COX and LOX products rescued gene expressions in S. exigua. As in mammalian systems, it is known that eicosanoids can induce gene expression of an antimicrobial peptide gene in B. mori 40) and are implicated in activating the imd signal pathway in D. melanogaster after lipopolysaccharide pattern recognition. 41) Stanley et al. 15) demonstrated a modulatory action of PGs on gene expression by direct exposure to cultured cells. Especially, in Anopheles albimanus, bacterial challenge activates PGE 2 synthesis, which induces gene expression of antimicrobial peptides in the midgut and fat body. 14) Several mammalian studies suggest that PG receptors are present at the nuclear membrane as well as the cell membrane, where they can modulate gene expression through nuclear calcium signals because nuclear calcium plays an instrumental role in DNA repair, chromatin condensation, apoptosis, and the regulation of gene expression via MAP kinase or NFkB activation. 42) In addition to antimicrobial peptide production, our data also indicated that COX and LOX products can modulate gene expression of dopa decarboxylase and prophenoloxidase, which are critical to form melanization by their catalytic activities to produce dopamine and quinone respectively. 43) Thus in addition to the effect of eicosanoids in recruiting hemocytes 44) by activating microaggregation and spreading behaviors near the microbial infection site, 16, 45) the role of eicosanoids in inducing both types of gene expression further facilitates phagocytosis and nodulation by completing melanization. Finally, induction of antimicrobial peptide production by eicosanoids removes the remaining microorganisms. This study also indicates that some PGs, such as PGB 2 and PGE 1 , did not induce gene expression of prophenoloxidase. This suggests that there are receptors on the oenocytoids that respond to specific PGs or that there are independent signal transduction pathways depending on PGs. For example, when PGA 1 and PGE 1 are independently exposed to a cultured cell line, they clearly induce different gene expression, which explain their different signal pathways via the membrane or the intracellular receptors of these two PGs. 15) The fact that different COX and LOX products induced cellular and humoral immune responses suggests that there are several types of endogenous eicosanoids and specific receptors on target cells in S. exigua. Alternatively, a few eicosanoid receptors can 46) Its several physiological actions are mediated by two types of G protein-coupled receptors. One is the LTB 4 receptor type-1 (BLT1), a high-affinity LTB 4 receptor highly expressed in leukocytes. 47) The other, BLT2, is a low-affinity LTB 4 receptor expressed more widely than BLT1 in human tissues. 48, 49) The high sensitivity of S. exigua to LTB 4 suggests that S. exigua possesses a mammalian BLT1-like receptor.
At low doses, different COX and LOX products showed significant additive effects in the nodule formation of hemocytes. Even though no eicosanoid receptors have been identified in insects, these data suggest that the different eicosanoid receptors after binding the ligands tested in this study share a common signal pathway to yield an additive effect. By contrast, mammalian systems indicate unique receptors and signal pathways of different eicosanoids, in which most eicosanoids are bound to their specific G proteincoupled membrane receptor, and their independent receptors have been identified. 50) Moreover, PGD 2 , the predominant PG generated by activated mast cells of inflammation and allergic responses, can bind two different receptors, DP1 and DP2, located on different leukocytes, and this results in opposite secondary signal environments in the cells. 51, 52) To explain our data on unique and additive effects of COX and LOX products, eicosanoid receptors must be identified in S. exigua, but several overlapping roles of COX and LOX products in mediating cellular and humoral immune responses suggest a common intracellular signal pathway of these eicosanoids in S. exigua.
